Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

0.6721
Delayed Data
As of 12:00pm ET
 -0.0979 / -12.71%
Today’s Change
0.61
Today|||52-Week Range
1.71
-52.33%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close0.77
Today’s open0.77
Day’s range0.67 - 0.78
Volume6,152
Average volume (3 months)23,301
Market cap$10.6M
Dividend yield--
Data as of 12:00pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)-29.05%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.15

Competitors

 Today’s
change
Today’s
% change
BVXVBiondVax Pharmaceuti...-0.24-6.15%
ATOSAtossa Genetics Inc-0.21-10.10%
EVOKEvoke Pharma Inc-0.03-1.86%
CYANCyanotech Corp-0.09-2.25%
Data as of 12:04pm ET, 12/05/2016

Financials

Last reporting dateNovember 29, 2016
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$0.00
Annual profit (last year)-$3.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts


Search for Jobs